Upgrade to SI Premium - Free Trial

RBC Capital Reiterates Sector Perform Rating on PTC Therapeutics (PTCT)

October 7, 2026 5:02 AM
RBC Capital analyst Brian Abrahams reiterated a Sector Perform rating and $85.00 price target on PTC Therapeutics (NASDAQ: PTCT).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments